219A.THeartseed, Inc.
Nov 13, 2026 — Q3 2026 Earnings Release
Chart by TradingViewThe schedule
- Fri13Nov
Quarterly earnings report evaluating recent revenue contraction to $1.5M and cash burn velocity.
- Fri12Feb
- Thu18Feb
Expected topline data readout for the company's leading iPSC-derived cardiovascular therapy.
- Thu25Mar
Full-year financial results alongside crucial operating guidance and CapEx forecasts for FY27.
- Fri14May
- Tue15Jun
Evaluation of regulatory pathways and regenerative medicine policies under President Trump's administration.
- Fri13Aug